CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 636 enrolled
Drug / intervention
Misoprostol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02083107
NCT02083107Phase 3Completed
CompareCT.gov

COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS

Ain Shams University·interventional·Posted Mar 11, 2014·Updated Dec 22, 2015

In Brief

A Phase 3 clinical trial evaluating Misoprostol and Placebo for Postpartum Hemorrhage. Completed, enrolled 636 participants across 1 site.

Detailed Summary

The aim of the work is to evaluate \& compare the effectiveness of rectally administered PGE1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before caesarean section to decrease blood loss during and after the operation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostpartum Hemorrhage
CountriesEgypt
Collaborators--

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 11, 2014
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.3 years ago

Interventions

Misoprostoldrug

Comparison of different routes of administration of 400 micro gram misoprostol

Placeboother